Let's focus on what we can do!

Facebook Twitter Instagram Linkedin

By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Facebook Twitter Instagram Linkedin

Online Platform By Disabled People for Disabled People

  • Home
  • >
  • Latest Headlines
  • >
  • FDA Asked to Speed Review of New Duchenne MD Treatments in Letter Signed by 109 US Lawmakers – Muscular Dystrophy News

FDA Asked to Speed Review of New Duchenne MD Treatments in Letter Signed by 109 US Lawmakers – Muscular Dystrophy News

Thursday, 25 February, 2016

Categories

FDA Asked to Speed Review of New Duchenne MD Treatments in Letter Signed by 109 US Lawmakers – Muscular Dystrophy News

The Muscular Dystrophy Association (MDA) describes Duchenne muscular dystrophy (DMD), one of nine categories of muscular dystrophy, as a genetic disorder characterized by progressive muscle degeneration and weakness, caused by an absence of a ...

Read More

Source:FDA Asked to Speed Review of New Duchenne MD Treatments in Letter Signed by 109 US Lawmakers - Muscular Dystrophy News

Categories :
  • Latest Headlines , 
  • Muscular Dystrophy , 
  • Uncategorized
Socials :

Recent posts

@abilitytoday
Let's share our
memories
@abilitytodayuk
Let's be
friends
@abilitytoday
Let's chat and hear
your voice
@ability-today
Let's get down to
Business
Ability Today to your inbox.

By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.

Ability Today to your inbox.

By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.

Our Awards and Partners

Donate to Ability Today CIC

(A Social Enterprise)

Donate to Ability Today

Copyright © 2022 All rights reserved

Facebook Twitter Instagram Linkedin